Retraction: Ablation of Adenosine Monophosphate-Activated Protein Kinase α1 in Vascular Smooth Muscle Cells Promotes Diet-Induced Atherosclerotic Calcification In Vivo (Circ Res. (2016) 119 (422–433) DOI: 10.1161/CIRCRESAHA.116.308301);Ablation of adenosine monophosphate-activated protein kinase α1 in vascular smooth muscle cells promotes diet-induced atherosclerotic calcification in vivo

Circulation Research

Volumn 119, Issue 3, 2016, Pages 422-433

  Cai, Zhejun ^a,b   Ding, Ye ^a   Zhang, Miao ^c   Lu, Qiulun ^a   Wu, Shengnan ^a   Zhu, Huaiping ^a   Song, Ping ^a   Zou, Ming Hui ^a  

^a GEORGIA STATE UNIVERSITY   (United States)

^b THE SECOND AFFILIATED HOSPITAL OF ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^c UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

Author keywords

AMP activated protein kinases; atherosclerosis; muscle, smooth, vascular; osteoblasts; osteogenesis; protein inhibitors of activated STAT; Runx2 protein; sumoylation

Indexed keywords

ADENOSINE PHOSPHATE ACTIVATED PROTEIN KINASE ALPHA1; ALPHA SMOOTH MUSCLE ACTIN; CD68 ANTIGEN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; METFORMIN; OXIDIZED LOW DENSITY LIPOPROTEIN; PHOSPHOPROTEIN; PHOSPHORYLATED PROTEIN INHIBITOR OF ACTIVATED STAT 1; PROTEASOME; SERINE; SUMO PROTEIN; TRANSCRIPTION FACTOR RUNX2; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG; AMPK ALPHA1 SUBUNIT, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA ROOT; ARTICLE; ATHEROSCLEROSIS; BRACHIOCEPHALIC TRUNK; CELL DIFFERENTIATION; CONTROLLED STUDY; CORONARY ARTERY CALCIFICATION; ENZYME ACTIVATION; IN VIVO STUDY; MACROPHAGE; MOUSE; NONHUMAN; OSTEOBLAST; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PROCESSING; SUMOYLATION; VASCULAR SMOOTH MUSCLE CELL; WESTERN DIET; ADVERSE EFFECTS; ANIMAL; CELL CULTURE; DEFICIENCY; ENZYMOLOGY; KNOCKOUT MOUSE; MALE; PATHOLOGY; SMOOTH MUSCLE CELL; VASCULAR CALCIFICATION; VASCULAR SMOOTH MUSCLE;

AMP-ACTIVATED PROTEIN KINASES; ANIMALS; ATHEROSCLEROSIS; CELLS, CULTURED; DIET, WESTERN; MALE; MICE; MICE, KNOCKOUT; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; VASCULAR CALCIFICATION;

EID: 84978079825     PISSN: 00097330     EISSN: 15244571     Source Type: Journal    
DOI: 10.1161/RES.0000000000000578     Document Type: Erratum

References (50)

1. Otsuka F, Sakakura K, Yahagi K, Joner M, Virmani R, Has our understanding of calcification in human coronary atherosclerosis progressed? Arterioscler Thromb Vasc Biol 2014 34 724 736. doi: 10.1161/ATVBAHA.113.302642
2. Ruiz JL, Hutcheson JD, Aikawa E, Cardiovascular calcification: current controversies and novel concepts. Cardiovasc Pathol 2015 24 207 212. doi: 10.1016/j.carpath.2015.03.002
3. Bentzon JF, Otsuka F, Virmani R, Falk E, Mechanisms of plaque formation and rupture. Circ Res 2014 114 1852 1866. doi: 10.1161/CIRCRESAHA.114.302721
4. Steitz SA, Speer MY, Curinga G, Yang HY, Haynes P, Aebersold R, Schinke T, Karsenty G, Giachelli CM, Smooth muscle cell phenotypic transition associated with calcification: upregulation of Cbfa1 and downregulation of smooth muscle lineage markers. Circ Res 2001 89 1147 1154
5. Sun Y, Byon CH, Yuan K, Chen J, Mao X, Heath JM, Javed A, Zhang K, Anderson PG, Chen Y, Smooth muscle cell-specific runx2 deficiency inhibits vascular calcification. Circ Res 2012 111 543 552. doi: 10.1161/CIRCRESAHA.112.267237
6. Abedin M, Tintut Y, Demer LL, Vascular calcification: mechanisms and clinical ramifications. Arterioscler Thromb Vasc Biol 2004 24 1161 1170. doi: 10.1161/01.ATV.0000133194.94939.42
7. Mody N, Parhami F, Sarafian TA, Demer LL, Oxidative stress modulates osteoblastic differentiation of vascular and bone cells. Free Radic Biol Med 2001 31 509 519
8. Byon CH, Javed A, Dai Q, Kappes JC, Clemens TL, Darley-Usmar VM, McDonald JM, Chen Y, Oxidative stress induces vascular calcification through modulation of the osteogenic transcription factor Runx2 by AKT signaling. J Biol Chem 2008 283 15319 15327. doi: 10.1074/jbc.M800021200
9. Heath JM, Sun Y, Yuan K, Bradley WE, Litovsky S, Dell'Italia LJ, Chatham JC, Wu H, Chen Y, Activation of AKT by O-linked N-Acetylglucosamine induces vascular calcification in diabetes mellitus. Circ Res 2014 114 1094 1102. doi: 10.1161/CIRCRESAHA.114.302968
10. Pugliese G, Iacobini C, Blasetti Fantauzzi C, Menini S, The dark and bright side of atherosclerotic calcification. Atherosclerosis 2015 238 220 230. doi: 10.1016/j.atherosclerosis.2014.12.011
11. Davies SP, Hawley SA, Woods A, Carling D, Haystead TA, Hardie DG, Purification of the AMP-Activated protein kinase on ATP-gamma-sepharose and analysis of its subunit structure. Eur J Biochem 1994 223 351 357
12. Mitchelhill KI, Stapleton D, Gao G, House C, Michell B, Katsis F, Witters LA, Kemp BE, Mammalian AMP-Activated protein kinase shares structural and functional homology with the catalytic domain of yeast Snf1 protein kinase. J Biol Chem 1994 269 2361 2364
13. Stapleton D, Mitchelhill KI, Gao G, Widmer J, Michell BJ, Teh T, House CM, Fernandez CS, Cox T, Witters LA, Kemp BE, Mammalian AMP-Activated protein kinase subfamily. J Biol Chem 1996 271 611 614
14. Goirand F, Solar M, Athea Y, Viollet B, Mateo P, Fortin D, Leclerc J, Hoerter J, Ventura-Clapier R, Garnier A, Activation of AMP kinase alpha1 subunit induces aortic vasorelaxation in mice. J Physiol 2007 581 1163 1171. doi: 10.1113/jphysiol.2007.132589
15. Bae HB, Zmijewski JW, Deshane JS, Tadie JM, Chaplin DD, Takashima S, Abraham E, AMP-Activated protein kinase enhances the phagocytic ability of macrophages and neutrophils. FASEB J 2011 25 4358 4368. doi: 10.1096/fj.11-190587
16. Wu Y, Song P, Zhang W, Activation of AMPK2 in adipocytes is essential for nicotine-induced insulin resistance in vivo. Nat Med 2015 21 373 382. doi: 10.1038/nm.3826
17. Hu X, Xu X, Lu Z, Zhang P, Fassett J, Zhang Y, Xin Y, Hall JL, Viollet B, Bache RJ, Huang Y, Chen Y, AMP activated protein kinase-2 regulates expression of estrogen-related receptor-a metabolic transcription factor related to heart failure development. Hypertension 2011 58 696 703. doi: 10.1161/HYPERTENSIONAHA.111.174128
18. Grahame Hardie D, AMP-Activated protein kinase: a key regulator of energy balance with many roles in human disease. J Intern Med 2014 276 543 559. doi: 10.1111/joim.12268
19. Dong Y, Zhang M, Liang B, Xie Z, Zhao Z, Asfa S, Choi HC, Zou MH, Reduction of AMP-Activated protein kinase alpha2 increases endoplasmic reticulum stress and atherosclerosis in vivo. Circulation 2010 121 792 803. doi: 10.1161/CIRCULATIONAHA.109.900928
20. Ou T, Hou X, Guan S, Dai J, Han W, Li R, Wang W, Qu X, Zhang M, Targeting AMPK signalling pathway with natural medicines for atherosclerosis therapy: an integration of in silico screening and in vitro assay. Nat Prod Res 2015 1 8
21. Bandow K, Kusuyama J, Kakimoto K, Ohnishi T, Matsuguchi T, AMP-Activated protein kinase (AMPK) activity negatively regulates chondrogenic differentiation. Bone 2015 74 125 133. doi: 10.1016/j.bone.2014.12.001
22. Kasai T, Bandow K, Suzuki H, Chiba N, Kakimoto K, Ohnishi T, Kawamoto S, Nagaoka E, Matsuguchi T, Osteoblast differentiation is functionally associated with decreased AMP kinase activity. J Cell Physiol 2009 221 740 749. doi: 10.1002/jcp.21917
23. Zhan JK, Wang YJ, Wang Y, Tang ZY, Tan P, Huang W, Liu YS, Adiponectin attenuates the osteoblastic differentiation of vascular smooth muscle cells through the AMPK/mTOR pathway. Exp Cell Res 2014 323 352 358. doi: 10.1016/j.yexcr.2014.02.016
24. Shah M, Kola B, Bataveljic A, Arnett TR, Viollet B, Saxon L, Korbonits M, Chenu C, AMP-Activated protein kinase (AMPK) activation regulates in vitro bone formation and bone mass. Bone 2010 47 309 319. doi: 10.1016/j.bone.2010.04.596
25. Komori T, Yagi H, Nomura S, Yamaguchi A, Sasaki K, Deguchi K, Shimizu Y, Bronson RT, Gao YH, Inada M, Sato M, Okamoto R, Kitamura Y, Yoshiki S, Kishimoto T, Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 1997 89 755 764
26. Engelse MA, Neele JM, Bronckers AL, Pannekoek H, de Vries CJ, Vascular calcification: expression patterns of the osteoblast-specific gene core binding factor alpha-1 and the protective factor matrix gla protein in human atherogenesis. Cardiovasc Res 2001 52 281 289
27. Tyson KL, Reynolds JL, McNair R, Zhang Q, Weissberg PL, Shanahan CM, Osteo/chondrocytic transcription factors and their target genes exhibit distinct patterns of expression in human arterial calcification. Arterioscler Thromb Vasc Biol 2003 23 489 494. doi: 10.1161/01.ATV.0000059406.92165.31
28. Cao X, Li H, Tao H, Wu N, Yu L, Zhang D, Lu X, Zhu J, Lu Z, Zhu Q, Metformin inhibits vascular calcification in female rat aortic smooth muscle cells via the AMPK-eNOS-NO pathway. Endocrinology 2013 154 3680 3689. doi: 10.1210/en.2013-1002
29. Proudfoot D, Davies JD, Skepper JN, Weissberg PL, Shanahan CM, Acetylated low-density lipoprotein stimulates human vascular smooth muscle cell calcification by promoting osteoblastic differentiation and inhibiting phagocytosis. Circulation 2002 106 3044 3050
30. Taylor J, Butcher M, Zeadin M, Politano A, Shaughnessy SG, Oxidized low-density lipoprotein promotes osteoblast differentiation in primary cultures of vascular smooth muscle cells by up-regulating Osterix expression in an Msx2-dependent manner. J Cell Biochem 2011 112 581 588. doi: 10.1002/jcb.22948
31. Deng L, Huang L, Sun Y, Heath JM, Wu H, Chen Y, Inhibition of FOXO1/3 promotes vascular calcification. Arterioscler Thromb Vasc Biol 2015 35 175 183. doi: 10.1161/ATVBAHA.114.304786
32. Kim JH, Jang JW, Lee YS, Lee JW, Chi XZ, Li YH, Kim MK, Kim DM, Choi BS, Kim J, Kim HM, van Wijnen A, Park I, Bae SC, RUNX family members are covalently modified and regulated by PIAS1-mediated sumoylation. Oncogenesis 2014 3 e101. doi: 10.1038/oncsis.2014.15
33. Cui Z, Scruggs SB, Gilda JE, Ping P, Gomes AV, Regulation of cardiac proteasomes by ubiquitination, SUMOylation, and beyond. J Mol Cell Cardiol 2014 71 32 42. doi: 10.1016/j.yjmcc.2013.10.008
34. Antico Arciuch VG, Tedesco L, Fuertes M, Arzt E, Role of RSUME in inflammation and cancer. FEBS Lett 2015 589 3330 3335. doi: 10.1016/j.febslet.2015.07.048
35. Heo KS, Chang E, Takei Y, Le NT, Woo CH, Sullivan MA, Morrell C, Fujiwara K, Abe J, Phosphorylation of protein inhibitor of activated STAT1 (PIAS1) by MAPK-Activated protein kinase-2 inhibits endothelial inflammation via increasing both PIAS1 transrepression and SUMO E3 ligase activity. Arterioscler Thromb Vasc Biol 2013 33 321 329. doi: 10.1161/ATVBAHA.112.300619
36. Xue Y, Zhou F, Zhu M, Ahmed K, Chen G, Yao X, GPS: a comprehensive www server for phosphorylation sites prediction. Nucleic Acids Res 2005 33 W184 W187. doi: 10.1093/nar/gki393
37. Gottfried E, Kunz-Schughart LA, Weber A, Rehli M, Peuker A, Müller A, Kastenberger M, Brockhoff G, Andreesen R, Kreutz M, Expression of CD68 in non-myeloid cell types. Scand J Immunol 2008 67 453 463. doi: 10.1111/j.1365-3083.2008.02091.x
38. Ducy P, Zhang R, Geoffroy V, Ridall AL, Karsenty G, Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation. Cell 1997 89 747 754
39. Jonason JH, Xiao G, Zhang M, Xing L, Chen D, Post-Translational Regulation of Runx2 in Bone and Cartilage. J Dent Res 2009 88 693 703. doi: 10.1177/0022034509341629
40. Choi YH, Kim YJ, Jeong HM, Jin YH, Yeo CY, Lee KY, Akt enhances Runx2 protein stability by regulating Smurf2 function during osteoblast differentiation. FEBS J 2014 281 3656 3666. doi: 10.1111/febs.12887
41. Jones DC, Wein MN, Oukka M, Hofstaetter JG, Glimcher MJ, Glimcher LH, Regulation of adult bone mass by the zinc finger adapter protein Schnurri-3. Science 2006 312 1223 1227. doi: 10.1126/science.1126313
42. Zhao L, Huang J, Zhang H, Wang Y, Matesic LE, Takahata M, Awad H, Chen D, Xing L, Tumor necrosis factor inhibits mesenchymal stem cell differentiation into osteoblasts via the ubiquitin E3 ligase Wwp1. Stem Cells 2011 29 1601 1610. doi: 10.1002/stem.703
43. Triggle CR, Ding H, Cardiovascular impact of drugs used in the treatment of diabetes. Ther Adv Chronic Dis 2014 5 245 268. doi: 10.1177/2040622314546125
44. Yeh CH, Chen TP, Wang YC, Lin YM, Fang SW, AMP-Activated protein kinase activation during cardioplegia-induced hypoxia/reoxygenation injury attenuates cardiomyocytic apoptosis via reduction of endoplasmic reticulum stress. Mediators Inflamm 2010 2010 130636. doi: 10.1155/2010/130636
45. Miyazaki-Anzai S, Masuda M, Demos-Davies KM, Keenan AL, Saunders SJ, Masuda R, Jablonski K, Cavasin MA, Kendrick J, Chonchol M, McKinsey TA, Levi M, Miyazaki M, Endoplasmic reticulum stress effector CCAAT/enhancer-binding protein homologous protein (CHOP) regulates chronic kidney disease-induced vascular calcification. J Am Heart Assoc 2014 3 e000949. doi: 10.1161/JAHA.114.000949
46. Mattila JT, Thomas AC, Nitric oxide synthase: non-canonical expression patterns. Front Immunol 2014 5 478. doi: 10.3389/fimmu.2014.00478
47. Raaz U, Schellinger IN, Chernogubova E, Transcription factor Runx2 promotes aortic fibrosis and stiffness in type 2 diabetes mellitus. Circ Res 2015 117 513 524. doi: 10.1161/CIRCRESAHA.115.306341
48. Mitchell GF, Hwang SJ, Vasan RS, Larson MG, Pencina MJ, Hamburg NM, Vita JA, Levy D, Benjamin EJ, Arterial stiffness and cardiovascular events: the Framingham Heart Study. Circulation 2010 121 505 511. doi: 10.1161/CIRCULATIONAHA.109.886655
49. Molinuevo MS, Schurman L, McCarthy AD, Cortizo AM, Tolosa MJ, Gangoiti MV, Arnol V, Sedlinsky C, Effect of metformin on bone marrow progenitor cell differentiation: in vivo and in vitro studies. J Bone Miner Res 2010 25 211 221. doi: 10.1359/jbmr.090732
50. Shimazu J, Wei J, Karsenty G, Smurf1 inhibits osteoblast differentiation, bone formation, and glucose homeostasis through Serine 148. Cell Rep 2016 15 27 35. doi: 10.1016/j.celrep.2016.03.003